Lanean...
Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system
BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...
Gorde:
| Argitaratua izan da: | Cancer Manag Res |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750847/ https://ncbi.nlm.nih.gov/pubmed/31571995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217375 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|